Resource Library
All resources
Filter By

Food for Thought with Gretchen – Obesity is a disease, not a character flaw
Obesity isn’t a willpower problem, and it never was.

Bridging the Gap: 3 reasons to rethink your employee obesity management plan
Obesity is a growing health concern and many still face significant barriers to accessing obesity care. Employers who invest in providing obesity care can foster a healthier, more engaged workforce, while reducing healthcare costs.

The New Era of Obesity Care: Navigating medications and access in a changing landscape
Join Dr. Fatima Cody Stanford, Dr. Richard Frank, and Veeneta Lakhani as they break down what toda’ys evolving treatment landscape means for benefit leaders, payers, and consultants.

Navigating Formulary Shifts: Understanding the nuances between Zepbound, Wegovy, and other obesity medications amidst formulary updates
What are the key considerations to ensure members are supported during a formulary change, and how can we ensure that people continue progressing toward better health, even if their coverage changes?

Solving fragmented care for cardiometabolic health with Dr. Cynthia Horner
Following our recent webinar with Amwell, Dr. Cynthia Horner, chief medical officer for Amwell, explored the issues plaguing the healthcare industry when it comes to cardiometabolic health and whole-person care.

Clinical Obesity Management Outcomes
With data from over 18,000 members, this infographic highlights the measurable success of Vida’s personalized, cost-effective approach to obesity care. Learn how our model supports sustainable weight loss, promotes smart medication use, and delivers an immediate return on investment for employers and health plans.

GLP-1 Coverage and Underserved Populations: The Impact of Social Determinants of Health on Obesity Treatment Access
Obesity rates in the US are soaring, especially among low-income and minority communities. Yet these same groups face the steepest barriers to accessing effective treatments like GLP-1s.

Obesity program provides cost-effective specialty care and manages GLP-1 trends
Almost half of people with excess weight turn to GLP-1s as a first-line treatment, leading to less sustainable outcomes and rising healthcare costs. By partnering with Vida, we are improving access to obesity specialty care and helping organizations manage costs
and deliver better results.
Download our newest case study to learn how you can lower costs and provide better wraparound solutions for your people with Vida.

SISC Case Study
Download our newest case study with SISC to learn how your people can also live a happier, healthier future with Vida.


How personalized care solves for the social determinants of health – webinar
Among the 47 million Americans living with cardiometabolic disorders, people of color are disproportionately affected, particularly Hispanic Americans.

5 Myths of Obesity Management: Separating truth from hype – webinar
How you can take action this year before obesity expenses completely fall off the rails? Learn more in this webinar.